Lewis is a Commercialisation Associate in the Life Sciences team.

He provides support for the identification and evaluation of new technologies, protection of intellectual property, and development of commercial opportunities arising from University research.

Prior to joining Cambridge Enterprise Lewis worked as a Scientist in the Biopharmaceutical Development department of AstraZeneca. In this role he supported the development of cell lines for the manufacturing of biopharmaceuticals across the companies portfolio.

Lewis has a PhD from the University of Manchester where his thesis focused on the production of small molecule therapeutics via synthetic biology. He also has a MPhil and BSc in Biochemistry from the University of Manchester.

Lewis joined CE in September 2024.